The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Phagocytosis of Apoptotic Cells by Macrophages Is Impaired in Atherosclerosis
Abstract
OBJECTIVE: Apoptotic cell death has been demonstrated in advanced human atherosclerotic plaques. Apoptotic cells (ACs) should be rapidly removed by macrophages, otherwise secondary necrosis occurs, which in turn elicits inflammatory responses and plaque progression. Therefore, we investigated the efficiency of phagocytosis of ACs by macrophages in atherosclerosis. METHODS AND RESULTS: Human endarterectomy specimens and human tonsils were costained for CD68 (macrophages) and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) (apoptosis). Free and phagocytized ACs were counted in both tissues. The ratio of free versus phagocytized AC was 19-times higher in human atherosclerotic plaques as compared with human tonsils, indicating a severe defect in clearance of AC. Impaired phagocytosis of AC was also detected in plaques from cholesterol-fed rabbits and did not further change with plaque progression. In vitro experiments with J774 or peritoneal mouse macrophages showed that several factors caused impaired phagocytosis of AC including cytoplasmic overload of macrophages with indigestible material (beads), free radical attack, and competitive inhibition among oxidized red blood cells, oxidized low-density lipoprotein and ACs for the same receptor(s) on the macrophage. CONCLUSIONS: Our data demonstrate that phagocytosis of ACs is impaired in atherosclerotic plaques, which is at least partly attributed to oxidative stress and cytoplasmic saturation with indigestible material.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The impaired ability of macrophage efferocytosis would enhance atherogenesis [139,140,141] and atherosclerotic plaque instability [142,143,144].”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Fitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
Oxidative Stress and Vascular Disease
Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150649.39934.13 · Cited by 1,618
Corpse clearance defines the meaning of cell death
Savill, J., & Fadok, V. A. (2000) · Nature · doi:10.1038/35037722 · Cited by 1,572
Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic Plaques
Mallat, Z., Hugel, B., Ohan, J., Lesèche, G., Freyssinet, J., & Tedgui, A. (1999) · Circulation · doi:10.1161/01.cir.99.3.348 · Cited by 636
Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences
Fadok, V. A., Bratton, D. L., & Henson, P. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14122 · Cited by 474
Chang, M.-K., Bergmark, C., Laurila, A., Hörkkö, S., Han, K., Friedman, P., Dennis, E. A., & Witztum, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6353 · Cited by 456
Elevated Levels of Oxidative DNA Damage and DNA Repair Enzymes in Human Atherosclerotic Plaques
Martinet, W., Knaapen, M., Meyer, G. R. Y. D., Herman, A. G., & Kockx, M. M. (2002) · Circulation · doi:10.1161/01.cir.0000026393.47805.21 · Cited by 448
Cited by
Sorted by citations
Items 301–400 of 508
Life span of monocytes and platelets: importance of interactions
Reuter, S. (2009) · Frontiers in bioscience · doi:10.2741/3388 · Cited by 17
Extracellular DNA as potential contributors to pathological calcification
Niu, L., Zhu, Y., Wan, M., Wang, C., Hao, X., Song, J., Lei, C., Qin, Z., Tay, F., & Niu, L. (2024) · Interdisciplinary Medicine · doi:10.1002/inmd.20230061 · Cited by 16
Defective efferocytosis of vascular cells in heart disease
Singh, B., Li, K. S., Cui, K., Peng, Q., Cowan, D. B., Wang, D., Chen, K., & Chen, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1031293 · Cited by 18
Macrophage Anti-inflammatory Behaviour in a Multiphase Model of Atherosclerotic Plaque Development
Ahmed, I. U., Byrne, H. M., & Myerscough, M. R. (2023) · Bulletin of Mathematical Biology · doi:10.1007/s11538-023-01142-7 · Cited by 16
Liu, Y., Huang, Q., He, M., Chen, T., & Chu, X. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.12.031 · Cited by 16
Macrophage apoptosis using alendronate in targeted nanoarchaeosomes
Jerez, H. E., Altube, M. J., Gándola, Y. B., González, L., González, M., Morilla, M. J., & Romero, E. L. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.01.001 · Cited by 15
Selective Depletion of Macrophages in Atherosclerotic Plaques
Martinet, W., & Meyer, G. R. Y. D. (2007) · Circulation Research · doi:10.1161/01.res.0000263397.14481.96 · Cited by 16
Rangarajan, S., Orujyan, D., Rangchaikul, P., & Radwan, M. M. (2022) · Biomedicines · doi:10.3390/biomedicines10112829 · Cited by 16
Extracellular vesicles and atherosclerotic peripheral arterial disease
Brown, P. A., & Brown, P. D. (2022) · Cardiovascular Pathology · doi:10.1016/j.carpath.2022.107510 · Cited by 15
Heterogeneity of Macrophages in Atherosclerosis
Stremmel, C., Stark, K., & Schulz, C. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1692665 · Cited by 16
Chang, T., Hsu, C., Huang, P., Chiang, C.-H., Leu, H., Huang, C., Chen, J., & Lin, S. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.06.041 · Cited by 15
Kim, J. H., Chakraborty, S., Jayaprakasha, G. K., Muthuchamy, M., & Patil, B. S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.043 · Cited by 15
Co-receptors are dispensable for tethering receptor-mediated phagocytosis of apoptotic cells
Park, B., Lee, J., Moon, H., Lee, G., Lee, D., Cho, J. H., & Park, D. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.140 · Cited by 15
Hu, X., Nan, Y., Zhang, Y., Fan, J., Wang, H., Bai, Y., Zhang, Y., Zhang, X., Zhu, Z., Cao, Z., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107486 · Cited by 16
Anti-inflammatory action of apoptotic cells in patients with acute coronary syndromes
Ferri, L., Maugeri, N., Rovere, P. Q., Calabrese, A., Ammirati, E., Cianflone, D., Maseri, A., & Manfredi, A. A. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.042 · Cited by 14
Vázquez, G., Solanki, S. A., Dube, P., Smedlund, K., & Ampem, P. T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-26974-0_9 · Cited by 14
Zhao, Y., Ye, D., Wang, J., Calpe‐Berdiel, L., Azzis, S. B. R. N., van Berkel, T. J. C., & Eck, M. V. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.020 · Cited by 14
Imaging apoptosis for detecting plaque instability: rendering death a brighter facade
Corsten, M. F., Reutelingsperger, C. P. M., & Hofstra, L. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.01.008 · Cited by 13
The various roles of TREM2 in cardiovascular disease
Wang, S., Cao, C., & Peng, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1462508 · Cited by 16
Frégeau, G., Sarduy, R., Elimam, H., Esposito, C. L., Mellal, K., Ménard, L., da Graça, S. D. L., Proulx, C., Zhang, J., Febbraio, M., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.06.010 · Cited by 13
The changing landscape of the vulnerable plaque: a call for fine-tuning of preclinical models
Buono, M. F., Slenders, L., Wesseling, M., Hartman, R. J. G., Monaco, C. G., den Ruijter, H. M., Pasterkamp, G., & Mokrý, M. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106924 · Cited by 13
Sun, Y., Gao, W. Z., Zhao, Y., Cao, W., Liu, Z., Cui, G., Tong, L., Lei, F., & Tang, B. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00221 · Cited by 13
TAM receptors and their ligand-mediated activation: Role in atherosclerosis
Cai, B., & Kasikara, C. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.09.001 · Cited by 13
Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
Gila-Díaz, A., Carrillo, G. H., Singh, P., & Ramiro‐Cortijo, D. (2021) · Antioxidants · doi:10.3390/antiox10060933 · Cited by 13
Chaudhary, S., Patidar, A., Dhiman, A., Chaubey, G. K., Dilawari, R., Talukdar, S., Modanwal, R., & Raje, M. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04168-8 · Cited by 13
Macrophage SR-B1 in atherosclerotic cardiovascular disease
Huby, T., & Goff, W. L. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000822 · Cited by 13
Szondy, Z., Korponay-Szabo, I. R., Király, R., & Fésüs, L. (2011) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9781118105771.ch7 · Cited by 13
Tang, X., Huang, Z., Wang, F., Chen, J., Qin, D., Peng, D., & Yu, B. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117374 · Cited by 13
Zhang, M., Wei, J., Sun, Y., He, C., Ma, S., Pan, X., & Zhu, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.008 · Cited by 15
Mechanism of efferocytosis in atherosclerosis
Shu, L.-X., Cao, L.-L., Guo, X., Wang, Z., & Wang, S. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02439-3 · Cited by 16
Biochemical and biophysical mechanisms macrophages use to tune phagocytic appetite
Bond, A., & Morrissey, M. A. (2025) · Journal of Cell Science · doi:10.1242/jcs.263513 · Cited by 12
Banesh, S., Layek, S., & Trivedi, V. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.01.004 · Cited by 12
Nasir, N. J. M., Heemskerk, H., Jenkins, J., Hamadee, N. H., Bunte, R. M., & Tucker‐Kellogg, L. (2023) · eLife · doi:10.7554/elife.85633 · Cited by 11
Physiological and pathological/ectopic mineralization: from composition to microstructure
Mu, Y., Gao, W., Zhou, Y., Xiao, L., & Xiao, Y. (2023) · Microstructures · doi:10.20517/microstructures.2023.05 · Cited by 12
Ning, H., Liu, D., Yu, X., & Guan, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5221 · Cited by 12
Life and death in the atherosclerotic plaque
Bennett, M. R. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833d2bfd · Cited by 12
The Impact of Insulin Resistance on Macrophage Death Pathways in Advanced Atherosclerosis
Tabas, I. A., Seimon, T. A., Arellano, J., Li, Y., Forcheron, F., Cui, D., Han, S., Liang, C., Tall, A. R., & Accili, D. (2007) · Novartis Foundation symposium · doi:10.1002/9780470985571.ch9 · Cited by 12
Dual Exosome Coating for Modulating Endothelial Function and Inflammation
Xiao, Y., Liu, J., Dai, F., Zhao, A., Huang, N., Zou, D., & Yang, P. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c02721 · Cited by 12
Yuan, Z., Li, H., Ruan, B. X., Huang, H., Li, Y., & Wang, J. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70637 · Cited by 11
The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach
Puylaert, P., Coornaert, I., Neutel, C. H. G., Dondelinger, Y., Delanghe, T., Bertrand, M. J. M., Guns, P., Meyer, G. R. Y. D., & Martinet, W. (2022) · Biomedicines · doi:10.3390/biomedicines10051016 · Cited by 11
Inflammatory Pathways in Coronary Artery Disease: Which Ones to Target for Secondary Prevention?
Cheng, W.-H., & Wang, Y. (2025) · Cells · doi:10.3390/cells14030153 · Cited by 11
Zou, D., Yang, P., Liu, J., Dai, F., Xiao, Y., Zhao, A., & Huang, N. (2023) · Advanced Biology · doi:10.1002/adbi.202200277 · Cited by 11
Park, J., Loh, S., Cho, E.-H., Choi, H., Na, T., Nemeno, J. G., Lee, J. I., Yoon, T. J., Choi, I., Lee, M. Y., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.059 · Cited by 11
Myeloid atg5 deletion impairs n-3 PUFA-mediated atheroprotection
Wang, Z., Sequeira, R. C., Zabalawi, M., Madenspacher, J. H., Boudyguina, E. Y., Ou, T., Nelson, J. M., Nie, Y., Zhao, Q., Fessler, M. B., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.01.004 · Cited by 10
Jadeja, R. N., Thounaojam, M. C., Jain, M., Devkar, R. V., & Ramachandran, A. V. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2011.618136 · Cited by 11
Li, Y., & Tabas, I. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806518 · Cited by 11
Connecting the Dots: How Injury in the Arterial Wall Contributes to Atherosclerotic Disease
Belhoul‐Fakir, H., Lawrence‐Brown, M. M. D., Thompson, P. L., Hamzah, J., & Jansen, S. J. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.10.004 · Cited by 13
Unravelling molecular mechanisms in atherosclerosis using cellular models and omics technologies
Kardassis, D., Vindis, C., Stancu, C. S., Toma, L., Gafencu, A. V., Georgescu, A., Alexandru, N., Molica, F., Kwak, B. R., Burlacu, A., et al. (2024) · Vascular Pharmacology · doi:10.1016/j.vph.2024.107452 · Cited by 12
The Impaired Mechanism and Facilitated Therapies of Efferocytosis in Atherosclerosis
Wang, Z., Su, J. Y., Gong, F., Xue, L., & Su, Z. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001311 · Cited by 10
Tyro3 receptor tyrosine kinases in the heterogeneity of apoptotic cell uptake
Jeffrey, L. C. (2009) · Frontiers in bioscience · doi:10.2741/3401 · Cited by 10
Environmental Factors Affecting Phagocytosis of Dying Cells:Smoking and Static Magnetic Fields
Dini, L., & Vergallo, C. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9293-0_15 · Cited by 10
Schrijvers, D. M., Meyer, G. R. Y. D., Kockx, M. M., Herman, A. G., & Martinet, W. (2007) · PubMed Central · Cited by 10
Xu, J., Wang, J., Zhang, H. P., Chen, Y., Zhang, X., Zhang, Y., Xie, M., Xiao, J., Qiu, J., & Wang, G. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101250 · Cited by 9
Kuna, J., Żuber, Z. M., Chmielewski, G., Gromadziński, L., & Krajewska–Włodarczyk, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052433 · Cited by 9
Lysophosphatidylglucoside/GPR55 signaling promotes foam cell formation in human M2c macrophages
Shimai, R., Hanafusa, K., Nakayama, H., Oshima, E., Kato, M., Kano, K., Matsuo, I., Miyazaki, T., Tokano, T., Hirabayashi, Y., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-39904-x · Cited by 9
Zhu, Y., Ren, S., Huang, H., Wu, J., You, X., Gao, J., Ren, Y., Wang, R., Zhao, W., & Tan, S. (2024) · The FASEB Journal · doi:10.1096/fj.202400639r · Cited by 8
Wang, Y., Zhu, X.-T., & Hu, Z.-P. (2025) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2025.106990 · Cited by 8
ATP8B1 regulates PIP2 localization and cleavage of pyroptotic executioner Gasdermin D
Bhandari, N., Prince, A., Khan, M. R., Traughber, C. A., Neupane, K., Lorkowski, S. W., Brubaker, G., Ertugral, E. G., Kothapalli, C. R., Dubyak, G., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2502798122 · Cited by 9
Yang, T., Minami, M., Yoshida, K., Nagata, M., Yamamoto, Y., Takayama, N., Suzuki, K. W., Miyata, T., Okawa, M., & Miyamoto, S. (2021) · Heart and Vessels · doi:10.1007/s00380-021-01983-z · Cited by 8
The Bidirectional Relationship between Cholesterol and Macrophage Polarization
Medbury, H. J. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000303 · Cited by 8
Ghobadi, H., Hosseini, N., & Aslani, M. R. (2020) · Lung · doi:10.1007/s00408-020-00348-z · Cited by 8
Lymphocyte cytotoxicity of oxLDL in patients with atherosclerosis.
Mahmoudi, M. J., Mahmoudi, M., Siassi, F., Shokri, F., Eshraghian, M. R., Zarnani, A., Chahardoli, R., Hedayat, M., Khoshnoodi, J., Nayeri, H., et al. (2011) · PubMed · doi:10.22034/iji.2011.16885 · Cited by 8
Genetic influence on vascular smooth muscle cell apoptosis
McVey, D. G., Andreadi, C., Gong, P., Stanczyk, P. J., Solomon, C. U., Turner, L., Liu, Y., Chen, R., Cao, J., Nelson, C. P., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06799-z · Cited by 8
Chambers, K. L., Myerscough, M. R., Watson, M. G., & Byrne, H. M. (2024) · Bulletin of Mathematical Biology · doi:10.1007/s11538-024-01342-9 · Cited by 7
Shao, Y., Yang, W. Y., Nanayakkara, G., Saaoud, F., Issa, M. B., Xu, K., Lu, Y., Jiang, X., Mohsin, S., Wang, H., et al. (2024) · International Journal of Drug Discovery and Pharmacology · doi:10.53941/ijddp.2024.100022 · Cited by 7
Reprogramming and targeting of cholesterol metabolism in tumor-associated macrophages
Ma, Q., Zhu, Y., Zhang, D., Su, X., Jiang, C., Zhang, Y., Zhang, X., Han, N., Shu, G., Yin, G., et al. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00236b · Cited by 7
Fang, S., Alrumaihi, F., Alwanian, W. M., Alharbi, H. O., Alnughymishi, N. A., Alfifi, S. M., Bennett, E. S., & Zhang, P. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103104 · Cited by 7
Angiotensin II and Atherosclerosis: A New Cardiovascular Risk Factor Beyond Hypertension
Morat, N., Civieri, G., Spezia, M., Menegolo, M., Bernava, G., Iliceto, S., Iop, L., & Tona, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157527 · Cited by 8
Henning, A. L., Venable, A. S., Prado, E., Sampson, J. N. B., & McFarlin, B. K. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.03.015 · Cited by 7
LRP-1 Binds Fibrinogen in a Sialylation-Dependent Manner: A Quartz Crystal Microbalance Study
Gao, D. L., & Johal, M. S. (2023) · Langmuir · doi:10.1021/acs.langmuir.3c00629 · Cited by 7
The Role of Macrophages in Atherosclerosis: Participants and Therapists
Liu, X., Pang, S., Jiang, Y., Wang, L., & Liu, Y. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07513-5 · Cited by 7
HDL and plaque regression in a multiphase model of early atherosclerosis
Ahmed, I. U., & Myerscough, M. R. (2024) · Mathematical Biosciences · doi:10.1016/j.mbs.2024.109208 · Cited by 8
Temmerman, L., Westra, M. M., Bot, I., van Vlijmen, B. J. M., van Bree, N. F. H. N., Bot, M., Habets, K. L. L., Keulers, T. G., van der Vlag, J., Cotter, T. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02771-4 · Cited by 8
Ilmawati, R. R., Amin, A. Z., & Amin, M. (2017) · Biology Medicine & Natural Product Chemistry · doi:10.14421/biomedich.2017.62.59-62 · Cited by 7
Macrophage ontogeny and functional diversity in cardiometabolic diseases
Gautier, E. L., Askia, H., Murcy, F., & Yvan‐Charvet, L. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.06.023 · Cited by 9
Iliodromitis, K. E., Seyfarth, M., Balogh, Z., Bogossian, H., Iliodromitis, E. K., & Triposkiadis, F. K. (2025) · Basic Research in Cardiology · doi:10.1007/s00395-025-01121-0 · Cited by 6
Monocytes/Macrophages and Atherogenesis
Kozlov, S. G., Riazantseva, T. A., Melnikov, I., Okhota, S., Vasenkova, V., Saburova, O., Avtaeva, Y., Guria, K. G., Prokofieva, L. V., & Ахнафович, Г. З. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210962 · Cited by 9
Guillet, S., Lazarov, T., Jordan, N., Boisson, B., Tello‐Lafoz, M., Craddock, B. P., Zhou, T., Nishi, C., Bareja, R., Yang, H., et al. (2024) · eLife · doi:10.7554/elife.96085.3 · Cited by 7
Zhao, Q., Wang, Z., Meyers, A. K., Madenspacher, J. H., Zabalawi, M., Zhang, Q., Boudyguina, E. Y., Hsu, F., McCall, C. E., Furdui, C. M., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.777098 · Cited by 6
Understanding the role of alternative macrophage phenotypes in human atherosclerosis
Kawai, K., Vozenilek, A. E., Kawakami, R., Sato, Y., Ghosh, S., Virmani, R., & Finn, A. V. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2111301 · Cited by 6
Millar, B., & de Gaetano, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125858 · Cited by 7
Sleiman, L., Beanlands, R. S., Hasu, M., Thabet, M., Norgaard, A., Chen, Y., Holčı́k, M., & Whitman, S. C. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000259 · Cited by 6
Cardiovascular Immunotherapy and the Role of Imaging
Zupančič, E., Fayad, Z. A., & Mulder, W. J. M. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309227 · Cited by 6
Shang, J., Yang, Q., Fan, W., Chen, Y., Tang, D., Guo, H., Xiong, B., Huang, S., & Zhang, X. (2021) · Chemistry - An Asian Journal · doi:10.1002/asia.202100031 · Cited by 6
Apoptosis and Efferocytosis in Inflammatory Diseases
Purnama, C. A., Meiliana, A., Barliana, M. I., Dandan, K. L., & Wijaya, A. (2021) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v13i3.1608 · Cited by 5
Schrijvers, D. M., Meyer, G. R. Y. D., Kockx, M. M., Herman, A. G., & Martinet, W. (2006) · Biomarker Insights · doi:10.1177/117727190600100018 · Cited by 6
Daemen, M. J. A. P., & Kooi, M. E. (2009) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2009.09.009 · Cited by 6
Mao, Q., Ran, H., Hu, Q., He, S., Lu, Y., Li, H., Chai, Y.-M., Chu, Z.-Y., Xu, Q., Ding, W., et al. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i5.101473 · Cited by 5
Vulnerable plaques in atherosclerosis: focus on angiogenesis-associated phenotypic crosstalk
Hou, X.-Z., Yang, Y.-T., & Yao, J.-M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1737140 · Cited by 5
Li, X., Ding, H., Feng, G., & Huang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122903 · Cited by 6
Namgaladze, D., Jennewein, C., Preiss, S., von Knethen, A., & Brüne, B. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800615-jlr200 · Cited by 5
Quantification of Apoptosis in Mouse Atherosclerotic Lesions
Figg, N. L., & Bennett, M. R. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2929-0_13 · Cited by 5
The Pathology of Atherosclerosis
Dunphy, M. P., & Strausś, H. W. (2007) · Springer eBooks · doi:10.1007/978-3-211-32509-4_2 · Cited by 5
Engineered immune-driven theranostics for clinical cardiology
Zheng, J.-B., Li, X., Zhu, J., Liu, C., Song, X., Wang, B., Deng, Y. W., Feng, Y.-X., Wang, Q., Liu, J., et al. (2025) · Military Medical Research · doi:10.1186/s40779-025-00664-6 · Cited by 4
Mu, W.-J., Wei, S.-Q., Peng, W.-Q., & Guo, L. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103141 · Cited by 4
Innate immunity: current understandings and future perspectives
Zou, C., Ma, T., Li, J., & Zhou, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02920-0 · Cited by 8
Efferocytosis: A new star of atherosclerotic plaques reversal
Liang, X., Tian, S., Zhang, H., Sun, S., Zhang, P., Li, J., Liu, Z., Zhang, Y., & Liu, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113904 · Cited by 4
Qian, A. S., Kluck, G. E. G., Yu, P., González, L., Balint, E., & Trigatti, B. L. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100782 · Cited by 6
Redefining Macrophage Heterogeneity in Atherosclerosis: A Focus on Possible Therapeutic Implications
Kanuri, B., Maremanda, K. P., Chattopadhyay, D., Essop, M. F., Lee, M. K. S., Murphy, A. J., & Nagareddy, P. R. (2025) · Comprehensive physiology · doi:10.1002/cph4.70008 · Cited by 6
Pan, Q., Chen, C., & Yang, Y. (2023) · Current Medical Science · doi:10.1007/s11596-023-2818-2 · Cited by 4
Metadata
- Authors
- Schrijvers, D. M., De Meyer, G. R. Y., Kockx, M. M., Herman, A. G., & Martinet, W.
- Affiliations
- University of Antwerp (BE)
- From the Division of Pharmacology (D.M.S., G.R.Y.D.M., M.M.K., A.G.H., W.M.), University of Antwerp, Wilrijk, Belgium; and the Department of Pathology (M.M.K.), AZ Middelheim, Antwerp, Belgium
- Venue
- Arteriosclerosis Thrombosis and Vascular Biology
- Published
- 2005-06
- Volume
- 25
- Issue
- 6
- Pages
- 1256-1261
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2163327518
- Cited by
- 509
- References
- 42
- Citations by year
- 2026: 13 · 2025: 32 · 2024: 34 · 2023: 31 · 2022: 34 · 2021: 33 · 2020: 21 · 2019: 24 · 2018: 29 · 2017: 32 · 2016: 20 · 2015: 25 · 2014: 21 · 2013: 24 · 2012: 16
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- phagocytosis of apoptotic cells, macrophages, atherosclerosis, atherosclerotic plaque, secondary necrosis, oxidative stress, oxidized LDL, plaque progression, cholesterol-fed rabbits, tonsil
- MeSH terms
- Aged, Animals, Carotid Artery Diseases, Cytoplasm, Erythrocytes, Female, Humans, Lipoproteins, LDL, Male, Necrosis, Phagocytosis, Rabbits, Palatine Tonsil, Apoptosis, Macrophages, Peritoneal, Oxidative Stress, U937 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review